Showing results (111-120 of 127) with videos related to

Sort By:
Pageof 13
International Journal of Hematology|May 26, 2019
Combined rituximab, bendamustine, and dexamethasone chemotherapy for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma: a multicenter phase II studyYosuke Matsumoto, Tsutomu Kobayashi, Yuji Shimura, et al.
Cancer Immunology, Immunotherapy : CII|May 17, 2024
The lymphocyte/monocyte ratio predicts the efficacy of isatuximab plus pomalidomide in multiple myeloma patientsYutaka Shimazu, Junya Kanda, Yoshiyuki Onda, et al.
European Journal of Haematology|January 21, 2021
Outcomes of ixazomib/lenalidomide/dexamethasone for multiple myeloma: A multicenter retrospective analysisTeruhito Takakuwa, Ryosuke Yamamura, Kensuke Ohta, et al.
International Journal of Hematology|January 31, 2018
Pomalidomide with or without dexamethasone for relapsed/refractory multiple myeloma in Japan: a retrospective analysis by the Kansai Myeloma ForumYayoi Matsumura-Kimoto, Junya Kuroda, Hitomi Kaneko, et al.
Therapeutic Advances in Hematology|July 5, 2022
Real-world effectiveness and safety analysis of carfilzomib-lenalidomide-dexamethasone and carfilzomib-dexamethasone in relapsed/refractory multiple myeloma: a multicenter retrospective analysisYoshiyuki Onda, Junya Kanda, Hitomi Kaneko, et al.
Hematological Oncology|September 4, 2018
Unsuppressed serum albumin levels may jeopardize the clinical relevance of the international staging system to patients with light chain myelomaTetsuhiro Kasamatsu, Shuji Ozaki, Takayuki Saitoh, et al.
Annals of Hematology|March 16, 2024
Efficacy of elotuzumab for multiple myeloma deteriorates after daratumumab: a multicenter retrospective studyNaokazu Nakamura, Nobuyoshi Arima, Teruhito Takakuwa, et al.
Hematological Oncology|March 16, 2021
Plateau is a prognostic factor of lenalidomide therapy for previously treated multiple myelomaTeruhito Takakuwa, Kensuke Ohta, Eiji Nakatani, et al.
Leukemia Research Reports|July 18, 2018
Retrospective analysis of primary plasma cell leukemia in Kansai Myeloma Forum registryAya Nakaya, Hideo Yagi, Hitomi Kaneko, et al.
International Journal of Hematology|September 5, 2023
Real-world data on induction therapy in patients with transplant-ineligible newly diagnosed multiple myeloma: retrospective analysis of 598 cases from Kansai Myeloma ForumYuji Shimura, Hirohiko Shibayama, Aya Nakaya, et al.
Pageof 13